MedTrace Logo

Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults

NCT06297421 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2024-07-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Fecal Microbiota Transplantation compared with placebo in the treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults.

Conditions

  • Irritable Bowel Syndrome With Diarrhea
  • Fecal Microbiota Transplantation
  • Mental Health Issue

Interventions

PROCEDURE

Fecal Microbiota Transplantation

Oral Fecal Microbiota Transplantation Capsule

PROCEDURE

Placebo

Oral Placebo Capsule

Sponsors & Collaborators

  • Shenzhen Hospital of Southern Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2026-01-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06297421 on ClinicalTrials.gov